About MedAustron
MedAustron is a company based in Wiener Neustadt (Austria) founded in 2007 was acquired by C-RAD in October 2018. MedAustron offers products and services including Ion Therapy and Research Services.
- Headquarter Wiener Neustadt, Austria
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medaustron
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$428.04 K (USD), Grant
Jun 02, 2023
-
Investors
European Union
& 2 more
-
Employee Count
Not available
-
Acquired by
C-RAD
(Oct 11, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MedAustron
MedAustron offers a comprehensive portfolio of products and services, including Ion Therapy and Research Services.
Ion therapy is offered as a precise cancer treatment method using protons and carbon ions
Research services are provided in clinical and particle therapy studies in collaboration with institutions
Funding Insights of MedAustron
Investors in MedAustron
MedAustron has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include European Union, Austria Wirtschaftsservice and C-RAD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Banking regulatory services are provided for Austrian financial institutions.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Oncology treatments are delivered through standalone clinics.
|
Locked | Locked | Locked |
Investor details for MedAustron
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MedAustron
Investment portfolio details for MedAustron
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MedAustron
Detailed financials for MedAustron
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medaustron Comparisons
Peer comparison for MedAustron
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MedAustron
Detailed competitors of MedAustron
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medaustron
Complete news archive for MedAustron
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MedAustron
MedAustron was founded in 2007 and raised its 1st funding round 9 years after it was founded.
MedAustron is headquartered in Wiener Neustadt, Austria. It is registered at Wiener Neustadt, Niederosterreich, Austria.
MedAustron was established in 2007 as a standalone facility focused on ion therapy and research, situated in Wiener Neustadt, Austria. Particle beam treatments for cancer are administered to patients, while scientific studies in radiation oncology and related fields are conducted. Operations emphasize precision therapy using protons and carbon ions, supporting both clinical care and collaborative research initiatives in the medical sector.
MedAustron offers Ion Therapy and Research Services.
MedAustron has 3 investors. Key investors include European Union, Austria Wirtschaftsservice, and C-RAD.